Inactive Instrument

Insiders LYSOGENE

Equities

LYS

FR0013233475

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Lysogene CFO Assumes Same Role at Mauna Kea Technologies	23-06-14	MT
French Gene Therapy Group Lysogene Makes Ad Interim CFO Permanent	23-02-06	MT
Lysogene Appoints Côme de La Tour du Pin as Chief Financial Officer	23-02-03	CI
Lysogene Announces New Board of Directors	22-09-16	CI
Lysogene Jumps 14% On New Chief Medical Officer's Appointment	22-02-07	MT
Lysogene Appoints Stéphane Durant des Aulnois as Chief Financial Officer and a Member of the Executive Committee	19-10-17	CI
Lysogene Announces the Appointment of Carole Deffez as New Independent Board Director	19-09-26	CI
Lysogene S.A. Announces Board Changes	19-05-22	CI
Lysogene Announces Management Changes	18-11-15	CI
Lysogene Announces Changes in the Composition of its Board of Directors	18-09-13	CI
Lysogene Announces the Nomination of Dr. Ralph Laufer as Chief Scientific Officer and Member of the Executive Team	18-05-15	GL
Lysogene Announces the Nomination of Dr. Ralph Laufer as Chief Scientific Officer and Member of the Executive Team	18-05-15	CI
Lysogene Announces Board Changes	18-04-23	CI
Lysogene S.A. Appoints Ralph Laufer as Chief Scientific Officer, Effective May 2, 2018	18-04-16	CI
Lysogene Announces Appointments to its Clinical Advisory Board	17-09-12	CI
Lysogene Nominates Philippe Mendels-Flandre as Chief Operating Officer and a Member of the Board of Directors	17-05-16	CI
Lysogene Appoints David Schilansky to Its Board	16-12-07	CI
Lysogene Appoints Kimberley S. Gannon as Chief Scientific Officer	16-06-20	CI
Lysogene Appoints Berndt A. Modig as Senior Financial Advisor and Sarah Ankri as Finance Director	15-11-09	CI
Lysogene Appoints Annette Clancy as Chair of the Board	15-04-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders LYSOGENE

Equities

LYS

FR0013233475

Insiders

Filters